May 4-5, 2022 MIT Webconference
The Longwood Healthcare Leaders Spring meeting is centered on MIT’s Koch Institute via webconference with leading biopharma CEOs, heads of R&D, top academic researchers, and healthcare investors, co-hosted by Nobel laureate and Biogen/Alnylam co-founder Phil Sharp.
Featured Speakers
These meetings are focused on accelerating the translation of discoveries into medicines to help patients; substantial donations enabled by these meetings benefit Life Science Cares, The Boston Foundation, BSO, Harvard Medical School, MIT, and other charities.
LONGWOOD HEALTHCARE LEADERS SPRING WEBCONFERENCE
AGENDA | MAY 4-5, 2022
WEDNESDAY, MAY 4, 2022
10:40 am
PLACING PATIENTS AT THE CENTER
Michael Ackermann, Chair, Tarsus
Stewart Campbell, CEO, Axial Therapeutics
Mary Fisher, CEO, Colorescience
Joanne Waldstreicher, CMO, Johnson & Johnson
Moderator: Al Beardsley, COO, Galera Therapeutics
11:15 am
MAINTAINING CROSS-INDUSTRY COLLABORATION
Angus Grant, CBO, BeiGene
Aamir Malik, Chief Business Innovation Officer, Pfizer
Rachel Mears, Partner, Jeito Capital
Amit Mehta, Head, Partnering, gRED, Genentech
Amanda Wagner, CEO, Immunitas
Moderator: Gaurica Chacko, Global Domain Leader, Life Sciences, Wipro
1:00 pm
ADVANCING PLATFORM TECHNOLOGIES
Manuel Aivado, CEO, Aileron Therapeutics
Pablo Cagnoni, CEO, Rubius Therapeutics
Simon Harnest, CIO, Metagenomi
Phil Johnson, CEO, Interius Bio
David Southwell, CEO, TScan Therapeutics
Moderator: Michal Preminger, Head, Innovation, Johnson & Johnson, East North America
1:50 pm
CLINICAL TRIAL EFFICIENCY
Christian Antoni, Chief Development Officer, EQRx
Aoife Brennan, CEO, Synlogic
Marc Lipsitch, Director, Center for Communicable Disease Dynamics, Harvard
James Sapirstein, CEO, First Wave Therapeutics
Moderator: Alise Reicin, CEO, Tectonic Therapeutics
9:20 am
HOW M&A SPURS INNOVATION
Liz Leveille, Head, BD&L Boston & European Innovation Hubs, Merck
Ivana Magovcevic-Liebisch, CEO, Vigil Neuroscience
Greg Mayes, CEO, Antios Therapeutics
Matthias Müllenbeck, Head, Global BD & Alliance Management, Merck KGaA
Moderator: Chad Shear, Principal, Fish & Richardson
8:50 am
SPOTLIGHT ON MIT INNOVATION
Regina Barzilay, Distinguished Professor for AI & Health, School of Engineering, MIT
Kipp Weiskopf, Valhalla Fellow, Whitehead Institute for Biomedical Research
Jonathan Weissman, Professor, Biology, MIT
Moderator: Jane Wilkinson, Executive Director, Koch Institute, MIT
8:30 am
REGULATORY KEYNOTE
Peter Marks, Director, Center for Biologics Evaluation and Research, FDA
Andy Plump, President, R&D, Takeda
Moderator: Christoph Westphal, General Partner, Longwood Fund
9:50 am
EXPEDITING RESEARCH FOR TREATMENTS AND CURES
Chun-Lin Chen, CEO, Medicilon
Raj Devraj, CEO, Rectify Pharmaceuticals
Bill Hinshaw, CEO, Axcella Therapeutics
Peter Lebowitz, Global Oncology Therapeutic Area Head, Janssen
Reenie McCarthy, CEO, Stealth BioTherapeutics
Moderator: Chen Schor, CEO, Adicet Bio
2:50 pm
DRUG DISCOVERY SCIENCES
Annalisa D’Andrea, President & Chief Scientific Officer, ImmuneID
Marion Dorsch, President & CSO, Atavistik Bio
Larry Hamann, CEO, Interdict Bio
Cigall Kadoch, Associate Professor, Dana-Farber Cancer Institute
Saul Kato, CEO, Herophilus
Moderator: Art Krieg, CSO, Checkmate Pharmaceuticals
3:40 pm
CULTIVATING AN ECOSYSTEM OF PARTNERS
Percival Barretto-Ko, CEO, Plexium
Marianne De Backer, EVP, Head, Global BD&L, Bayer
Aakanksha Khandelwal, Global Commercial Lead, Oncology, Daiichi Sankyo
Chris Viehbacher, Founding Partner, Gurnet Point Capital
Henry Walke, Director of the Center for Preparedness and Response, CDC
Moderator: Ari Schaefer, Co-President, Klick Health
4:10 pm
MAKING SMART INVESTMENTS
Lori Hu, Managing Director, Vertex Ventures HC
Matthias Kleinz, SVP, Translational Sciences, UPMC Enterprises
Kyle Lefkoff, General Partner, Boulder Ventures
Judith Li, Partner, Lilly Asia Ventures
Marie-Claire Peakman, Principal, Pfizer Ventures
Moderator: Aleks Radovic-Moreno, Partner, Longwood Fund
2:20 pm
DESIGNING THE DEAL
Robert Blum, CEO, Cytokinetics
Jennifer Cayer, CBO, Pulmocide
Travis Engelman, Head, BD, Cytiva
Philippe Lopes-Fernandes, CBO, Ipsen
Brian Silver, CFO, TScan Therapeutics
Moderator: Brian McVeigh, CEO, Code Biotherapeutics
11:50 pm
CREATING A WORLD WITHOUT DISEASE
Mike Devoy, CMO, Bayer Pharmaceuticals
Bettina Cockroft, CMO, Sangamo
Mike Rosenblatt, Senior Partner, Flagship Pioneering
Ryan Saadi, CEO, Tevogen Bio
Skip Virgin, CSO, Vir Biotechnology
Moderator: Bill Hait, Global Head, External Innovation, Johnson & Johnson
12:25 pm
ACCELERATING DRUG DEVELOPMENT
JC Gutierrez-Ramos, CSO, Danaher
Samit Hirawat, EVP, CMO, Global Drug Development, Bristol Myers Squibb
Rich Moscicki, CMO & EVP, Science & Regulatory Advocacy, PhRMA
Sesha Neervannan, COO, Tarsus
Andrew Pecora, President & Chief Clinical Investigator, Celularity
Moderator: David Weinreich, EVP, Head, Global Clinical Development, Regeneron
4:40 pm
LONGWOOD FUND UPDATE
Aleks Radovic-Moreno, Partner, Longwood Fund
3:20 pm
FIRESIDE CHAT
David Loew, CEO, Ipsen
Clay Siegall, CEO, Seagen
Moderator: Colin Hill, CEO, GNS Healthcare
1:30 pm
FIRESIDE CHAT
Kabir Nath, CEO, Otsuka US
Ray Sanchez, CMO, Cerevel Therapeutics
Moderator: John Adkisson, President & CEO, Fish & Richardson
7:00 am
LONGWOOD FUND INTRODUCTION
Christoph Westphal, General Partner, Longwood Fund
7:30 am
NEWCO TO ESTABLISHED: BUILDING A BIOTECH